Cargando…
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial
Objective To determine if it is possible to stabilise the cerebral oxygenation of extremely preterm infants monitored by cerebral near infrared spectroscopy (NIRS) oximetry. Design Phase II randomised, single blinded, parallel clinical trial. Setting Eight tertiary neonatal intensive care units in e...
Autores principales: | Hyttel-Sorensen, Simon, Pellicer, Adelina, Alderliesten, Thomas, Austin, Topun, van Bel, Frank, Benders, Manon, Claris, Olivier, Dempsey, Eugene, Franz, Axel R, Fumagalli, Monica, Gluud, Christian, Grevstad, Berit, Hagmann, Cornelia, Lemmers, Petra, van Oeveren, Wim, Pichler, Gerhard, Plomgaard, Anne Mette, Riera, Joan, Sanchez, Laura, Winkel, Per, Wolf, Martin, Greisen, Gorm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283997/ https://www.ncbi.nlm.nih.gov/pubmed/25569128 http://dx.doi.org/10.1136/bmj.g7635 |
Ejemplares similares
-
No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life
por: Plomgaard, Anne M., et al.
Publicado: (2018) -
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial
por: Plomgaard, Anne M., et al.
Publicado: (2017) -
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury
por: Plomgaard, Anne M., et al.
Publicado: (2016) -
Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments
por: Plomgaard, Anne M, et al.
Publicado: (2016) -
A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial
por: Hyttel-Sorensen, Simon, et al.
Publicado: (2013)